We are live on ! Find out more
DRTX

DURATA THERAPEUTICS INC COM STK (DE)
DRTX

Delisted

DRTX was delisted on the 17th of November, 2014.

Back to rankings

74 hedge funds and large institutions have $229M invested in DURATA THERAPEUTICS INC COM STK (DE) in 2014 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 30 increasing their positions, 10 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 10

136% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 11

33% more capital invested

Capital invested by funds: $172M → $229M (+$56.8M)

25% more funds holding

Funds holding: 59 → 74 (+15)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

57% less call options, than puts

Call options by funds: $2.41M | Put options by funds: $5.55M

Holders
74
Holders Change
+15
Holders Change %
+25.42%
% of All Funds
2.13%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
26
Increased
30
Reduced
10
Closed
11
Calls
$2.41M
Puts
$5.55M
Net Calls
-$3.14M
Net Calls Change
-$3.2M

Top Buyers

Rank Fund Capital Flow
1
O
OppenheimerFunds
New York
+$14.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.9M
3
GIM
Granahan Investment Management
Massachusetts
+$2.43M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$1.52M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$1.08M

Top Sellers

Rank Fund Capital Flow
1
AC
Aisling Capital
New York
-$14.9M
2
DCM
Discovery Capital Management
Connecticut
-$12.6M
3
SC
Sophrosyne Capital
New York
-$1.42M
4
Millennium Management
Millennium Management
New York
-$852K
5
SIM
SSI Investment Management
California
-$459K
Name Holding Trade Value Shares
Change 		Change in
Stake
TCIM
26
TIAA CREF Investment Management
New York
$988K +$116K +7,768 +15%
TAM
27
Tocqueville Asset Management
New York
$937K +$44.7K +3,000 +6%
AIG
28
American International Group
New York
$931K +$667K +44,803 +453%
PP
29
PDT Partners
New York
$878K +$768K +51,556 New
BIM
30
BlackRock Investment Management
Delaware
$765K +$127K +8,525 +23%
RFC
31
Russell Frank Company
Washington
$721K +$109K +7,292 +15%
NFA
32
Nationwide Fund Advisors
Ohio
$715K +$28.8K +1,931 +5%
SIM
33
Spark Investment Management
New York
$671K +$587K +39,442 New
Group One Trading
34
Group One Trading
Illinois
$648K +$512K +34,398 +943%
Millennium Management
35
Millennium Management
New York
$646K -$852K -57,249 -60%
AQR Capital Management
36
AQR Capital Management
Connecticut
$572K +$179K +12,000 +56%
AI
37
Analytic Investors
California
$555K +$485K +32,563 New
GF
38
Gabelli Funds
New York
$545K +$476K +32,000 New
U
39
UBS
Switzerland
$513K +$436K +29,281 +3,309%
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$483K +$71.5K +4,800 +20%
HLA
41
Hamilton Lane Advisors
Pennsylvania
$447K +$391K +26,228 New
Charles Schwab
42
Charles Schwab
California
$431K – – –
TA
43
Teachers Advisors
New York
$366K +$47.5K +3,190 +17%
State Board of Administration of Florida Retirement System
44
State Board of Administration of Florida Retirement System
Florida
$362K +$316K +21,233 New
PAM
45
Panagora Asset Management
Massachusetts
$337K +$295K +19,811 New
California Public Employees Retirement System
46
California Public Employees Retirement System
California
$309K +$270K +18,167 New
Wells Fargo
47
Wells Fargo
California
$281K +$238 +16 +0.1%
Two Sigma Investments
48
Two Sigma Investments
New York
$257K +$224K +15,069 New
Citadel Advisors
49
Citadel Advisors
Florida
$241K +$210K +14,127 New
KCM
50
Kanawha Capital Management
Virginia
$221K – – –
1
2
3 4

DRTX Hedge Fund Activity: Q2 2014 in Review

74 of the 3,480 institutional investors tracked by Wall St. Rank reported a position in DURATA THERAPEUTICS INC COM STK (DE) (DRTX) for Q2 2014, worth a combined $229M — up 33% from $172M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new DRTX positions and 11 closed out — a net gain of 15 holders — while 30 added to existing stakes and 10 trimmed.

The largest buyer was OppenheimerFunds, opening a new position worth an estimated $14.9M. The largest seller was Aisling Capital, cutting an estimated $14.9M.

  • 74 institutional investors held DURATA THERAPEUTICS INC COM STK (DE) (DRTX) as of Q2 2014, up from 59 in Q1 2014.
  • Funds reported $229M of DURATA THERAPEUTICS INC COM STK (DE) stock for Q2 2014, up 33% quarter-over-quarter.
  • 26 funds opened new DURATA THERAPEUTICS INC COM STK (DE) positions in Q2 2014 and 11 closed out, a net change of +15 holders.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) buyer in Q2 2014 was OppenheimerFunds, an estimated $14.9M added.
  • The largest DURATA THERAPEUTICS INC COM STK (DE) seller in Q2 2014 was Aisling Capital, an estimated $14.9M sold.

Based on aggregated 13F filings for Q2 2014.